Skip to product information
1 of 1

Cartalax (25mg)

Cartalax (25mg)

As low as $52 each!
Regular price $60.00
Regular price Sale price $60.00
Sale Sold out
Shipping calculated at checkout.
  • FREE SHIPPING
  • 99+% PURITY
  • MADE IN USA
View full details

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

What is Cartalax (25mg)?

What is Cartalax?

Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid (AED), designed as a tissue-specific bioregulator targeting connective tissue cells, especially fibroblasts. Laboratory studies suggest it may support proliferation, modulate apoptosis, and balance extracellular matrix dynamics—particularly in aging or injured cell models.

Chemical Structure of Cartalax

Cartalax has the amino acid sequence Ala–Glu–Asp, with the chemical formula C₁₂H₁₉N₃O₈ and a molecular weight of approximately 333.29 Da. Its small, polar structure enables cellular entry and interaction with nuclear components, as observed in tissue culture studies.

What Are the Effects of Cartalax?

  • Fibroblast Proliferation: In cultured fibroblast models, Cartalax increases proliferation markers such as Ki‑67 and CD98hc while reducing caspase‑3–mediated apoptosis—suggesting enhanced cell survival and replicative capacity.
  • Apoptosis Regulation: Exposure to Cartalax correlates with decreased expression of pro-apoptotic p53, indicating potential for longevity enhancement in cellular models.
  • Extracellular Matrix Stabilization: Cartalax downregulates MMP‑9 in aged fibroblast cultures, potentially preserving collagen and extracellular matrix integrity.
  • Cell-Specific Gene Expression: Research implies modulation of senescence-associated genes (p16, p21) and the longevity-associated enzyme SIRT‑6 in aging cell models.
  • Epigenetic and Nuclear Effects: Preclinical data suggest Cartalax may interact with nuclear DNA or regulatory proteins, affecting transcription of matrix-related genes and stress-resilience pathways.

Citations

  1. PubChem Compound Summary for Cartalax (AED peptide). Overview of Cartalax
  2. Pep‑Pedia: “Cartalax (AED peptide) – fibroblast proliferation and apoptosis regulation.” Overview of Cartalax
  3. Pep‑Pedia: “Gene-expression and epigenetic effects of Cartalax.” Overview of Cartalax
  4. Battle Born Peptides: “Cartalax for cartilage, connective tissue, and inflammatory studies.” Overview of Cartalax
  5. PubChem re-confirmation: Cartalax sequence and synonyms (AED, T‑31). Overview of Cartalax

COA

Certificate of Analysis

HPLC

High Performance Liquid Chromatography

High Quality - 99% Purity Guaranteed

Product Quality Guarantee

We are continuously conducting HPLC test on all of our raw powders as well as finished products to ensure the quality of our products. You can have the product you bought from us tested at any HPLC licensed testing facility and if the results are negative, we will refund the following:
HPLC TEST FEE
$100
PLUS Total amount of the Order + Shipping Fee

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)